Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Shull (Barcelona, Spain), O. Jorba (Barcelona, Spain), C. Lara (Barcelona, Spain), M. Olid (Barcelona, Spain), M. Pay (Barcelona, Spain), G. Bermudo (Barcelona, Spain), G. Suarez Curatin (Barcelona, Spain), V. Vicens (Barcelona, Spain), L. Planas (Barcelona, Spain), J. Bordas (Barcelona, Spain), P. Rivera Ortega (Manchester, United Kingdom), M. Molina Molina (Barcelona, Spain), C. Group (Barcelona, Spain). Mapping IPF helps identify geographic regions at higher risk for disease development. 1796

Member's Comments

No comment yet.

Related content which might interest you: Novel strategy to identify genetic risk factors for COPD severity: genetically isolated populations Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD Year: 2008 Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate Source: Eur Respir J 2010; 35: 768-775 Year: 2010 A genome-wide association study on the risk variations for susceptibility to early COPD Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Projections of the future burden of COPD in the Netherlands by disease severity using a dynamic population model of disease progression Source: Eur Respir J 2004; 24: Suppl. 48, 700s Year: 2004 Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis. Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 A large-scale genome-wide association analysis of lung function in the Chinese population identifies novel loci and highlights shared genetic aetiology with obesity Source: Eur Respir J, 58 (4) 2100199; 10.1183/13993003.00199-2021 Year: 2021 Population segmentation to identify priority targets for identification and behaviour change interventions in COPD Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011 Will the population ²at risk for COPD² develop COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 218s Year: 2005 A BTNL2 gene variant confers to sarcoidosis susceptibility by an increased risk towards the chronic form of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 148s Year: 2006 Genome-wide association analysis reveals 12q13.3–q14.1 as new risk locus for sarcoidosis Source: Eur Respir J 2013; 41: 888-900 Year: 2013 Knowledge and attitudes of TB patients about risk factors which contribute the genesis of their disease Source: Eur Respir J 2005; 26: Suppl. 49, 417s Year: 2005 Genetic typing of bronchial asthma afflicted people according to polymorphous genes for the purpose of disease progress risk factors detection Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 Identification of novel rare genetic variants associated with COPD in the general population Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us? Year: 2018 Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation Source: Eur Respir J 2011; 38: 749-751 Year: 2011 Genome-wide association study identifies new COPD risk locus, PDE4D, in Korean population Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Investigating tensin1 expression and the presence of SNP identified in GWAS in COPD Source: International Congress 2016 – Mechanisms of disease Year: 2016 Occupational risk factors may be of importance to define populations suitable to screening of lung cancer Source: Annual Congress 2011 - Work, the environment and respiratory disease Year: 2011 Incidence and risk factors for structural lung disease following SARS-CoV-2 infection Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Subclinical structural or functional lung changes is associated with higher risk of developing lower respiratory tract infection in a tertiary RA cohort. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021